Philippe Bridonneau

Title: Philippe Bridonneau: Innovator in HPV Research

Introduction

Philippe Bridonneau is a notable inventor based in Rebigues, France. He has made significant contributions to the field of immunology, particularly in the development of innovative solutions for combating human papillomavirus (HPV) infections.

Latest Patents

Bridonneau holds a patent for "HPV/CyaA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders." This invention relates to a chimeric protein that includes a N-terminal part of a CyaA protein, a heterologous polypeptide with antigens from various HPVs, and a C-terminal part of a CyaA protein. Additionally, the invention encompasses a polynucleotide encoding this chimeric protein, as well as a composition that includes at least one chimeric protein and its prophylactic and therapeutic applications.

Career Highlights

Throughout his career, Philippe Bridonneau has worked with several prominent companies, including Genticel and Genkyotex. His work has focused on advancing the understanding and treatment of HPV-related disorders, showcasing his commitment to public health and innovation.

Collaborations

Bridonneau has collaborated with notable colleagues such as Yolande Misseri and Anne Goubier. These partnerships have contributed to the development of his groundbreaking research and inventions.

Conclusion

Philippe Bridonneau's work in the field of HPV research exemplifies the impact of innovative thinking in addressing public health challenges. His contributions continue to pave the way for advancements in immunology and therapeutic solutions.